Intended use at a glance
A short, quotable summary. Link directly to it with aussiepeptideshub.com/compliance#intended-use.
- What these products are: laboratory reference materials, supplied as lyophilised powder in sealed vials for in-vitro (test-tube and cell-culture) research.
- Who they are for: qualified researchers, or buyers purchasing on behalf of a research entity, aged 18 or over.
- What they are not: not medicines, not therapeutic goods, not TGA approved, not dietary supplements, and not cosmetics.
- How they must not be used: not for human or veterinary use — not to be consumed, injected, applied, inhaled or otherwise administered to a person or an animal, and not for any diagnostic or treatment purpose.
- What we do not provide: dosing, cycles, protocols, administration guidance, or any advice about personal use. We will not answer those questions.
For research use only
All products listed on this website — including but not limited to BPC-157, TB-500, CJC-1295, Ipamorelin, GHRP-2, GHRP-6, Hexarelin, Sermorelin, Tesamorelin, Epitalon, NAD+, MK-677, GHK-Cu, Melanotan II, Semaglutide, Tirzepatide and Retatrutide — are sold solely as reference materials for laboratory and in-vitro research. They are not medicines, are not approved by the Therapeutic Goods Administration (TGA), and are not intended for human or veterinary diagnostic, therapeutic, cosmetic or in-vivo use. No product on this site has been evaluated for safety or efficacy in people, and no claim is made that any product is safe or effective for any human or animal purpose.
By placing an order you acknowledge that you are a qualified researcher (or buying on behalf of a research entity), that you will handle the material under appropriate laboratory controls, and that you will not consume, inject, administer or otherwise introduce any product into a human or animal body.
Australian regulatory context
Many peptides we supply are classified under the Poisons Standard (SUSMP) as Schedule 4 (Prescription Only) substances in Australia. Some — including Melanotan II and certain GLP-1 analogues — are subject to additional restrictions or TGA safety alerts. Supply for in-vitro laboratory research outside the therapeutic goods framework is permitted only when no therapeutic claim is made and the product is clearly labelled for research use.
Customers are responsible for compliance with all federal, state and territory laws that apply to them, including the Therapeutic Goods Act 1989 (Cth), the Customs Act 1901 (Cth) and any state Poisons Acts.
Medical disclaimer — no medical advice
Nothing on this website is medical advice, and nothing on it should be treated as a recommendation to use any substance in a person or an animal. Product descriptions, research guides, FAQ entries and any linked literature are provided as educational reference about published laboratory research only.
Specifically:
- No content here diagnoses, treats, cures or prevents any disease, symptom or condition, and it must not be relied on for that purpose.
- No content describes an approved indication. Where a compound is mentioned in the same sentence as a biological process, that describes a published pre-clinical or in-vitro finding — not an outcome you should expect in a person.
- Safety, side effects, interactions and long-term effects in humans are, for most of these compounds, unestablished. Absence of a warning is not evidence of safety.
- We do not employ your treating clinician and we cannot advise on your health. Always consult a registered Australian medical practitioner before making any decision about your health, medication or treatment, and call 000 in an emergency.
No advertising of therapeutic use
In line with the Therapeutic Goods Advertising Code, we do not promote any product on this site as having therapeutic benefit in humans. Any references to mechanism, receptor activity, or research findings describe pre-clinical or laboratory studies only. We will not respond to questions about dosing, cycles, administration or personal use.
Age & eligibility
Customers must be at least 18 years of age. We reserve the right to refuse or cancel any order where research-use intent cannot be reasonably established, including bulk orders to residential addresses or orders showing patterns inconsistent with laboratory use.
Reporting & concerns
Adverse events involving unapproved peptide products can be reported to the TGA. If you have a concern about an Aussie Peptides product or batch, contact us at compliance@aussiepeptideshub.com with the SKU and batch number from your invoice.